Abbott (NYSE:ABT) faces a proposed class action lawsuit related to alleged tracking tools used with its FreeStyle Libre ...
Monitoring blood glucose levels should be a part of a daily routine, especially for people with Type 1 or Type 2 diabetes ... from anywhere at any time. The FreeStyle Libre Glucose Monitoring System ...
The US Food and Drug Administration (FDA) has tagged Abbott’s recent recall of its faulty FreeStyle Libre 3 sensors as Class ...
Abbott launched an over-the-counter continuous glucose monitoring system, Lingo, for adults not on insulin -- the second such ...
If you're a fan of Kindle e-readers and want to enjoy all of the features and functions these e-readers have to offer, ...
Some people are facing delays in filling prescriptions for the glucose sensor. Abbott expects to resolve the problem soon.
Abbott Laboratories' (NYSE: ABT) business has been a bit of a roller coaster. The pandemic disrupted its medical device ...
Abbott Diabetes Care, Inc. is recalling its FreeStyle Libre 3 sensors after finding a small number of the sensors may provide incorrect high glucose readings, which, if undetected may pose ...